Introduction
Genetic neurological disorders offer a powerful approach to identify proteins involved in the setting up of neural networks. They thus provide further insight into the molecular processes underlying axon growth and guidance and neuron migration. Kallmann syndrome (KS) (Kallmann et al., 1944; de Morsier, 1955 ) is a human genetic disease that impairs cell migration and axon elongation. In KS patients, both the elongation of olfactory neuron axons and the migration of gonadotropin-releasing hormone (GnRH) synthesizing neurons, are defective (Schwanzel-Fukuda et al., 1989) . The KAL-1 gene, underlying the X-linked form of the disease (Franco et al. 1991; Legouis et al. 1991) , encodes a cell matrix protein, anosmin-1, that displays cell adhesion, neurite outgrowth, axon guidance and axon branch-promoting activities in vitro (Soussi-Yanicostas et al., 1996; 1998; 2002; Rugarli et al., 1996; Hardelin et al., 1999; Robertson et al., 2001) . Cariboni et al. (2004) have also demonstrated that anosmin-1 affects the migration of GnRH neurons in vitro and we have established that it also modulates the migratory properties of a glial cell population in vitro, namely the oligodendrocyte precursors in the developing optic nerve in rodents (Bribian et al., 2006) .
In zebrafish, two KAL-1 orthologues, namely kal1a and kal1b (Ardouin et al., 2000) , encoding anosmin-1a and anosmin-1b, respectively, have been identified. Whitlock et al. (2005) and Okubo et al. (2006) have demonstrated an essential requirement for anosmin-1a, but not for anosmin-1b, in GnRH cell migration in zebrafish and medaka, respectively. In addition, while kal1a and kal1b display distinct patterns of transcription during zebrafish development, both genes are expressed to high levels in another migrating cell population, the PLLP (Ardouin et al., 2000) . The lateral line (LL) is a mechanosensory organ of fish and amphibians that senses water movements and thus helps fish to avoid obstacles and predators, detect prey, and swim in groups. In fish, the LL comprises several rows of small, discrete and evenly spaced sensory organs, the neuromasts, which contain some ten sensory hair cells each. The posterior LL (PLL), the main branch of which derives from the migration of the PLLP, comprises the neuromasts located on the flanks and tail of fish. In the zebrafish, the PLLP originates from a sensory placode that forms just caudal to the otic vesicle at about 18 hours post-fertilization (hpf) (Kimmel et al., 1995) and begins to migrate along the myoseptum toward the tail at around 20 hpf (for reviews, see Dambly-Chaudière et al., 2003; Ghysen and Dambly-Chaudière, 2004; Lecaudey and Gilmour, 2006) . At regular intervals throughout its journey, small groups of cells located at the trailing edge of the PLLP progressively inserm-00289099, version 1 -2 Jul 2008 slow down and then stop to split off from the migrating primordium. These groups of cells, the proneuromasts, will eventually differentiate into neuromasts. During its travel, the PLLP evenly deposits 5 neuromasts along the flanks of the fish and 2 to 3 neuromasts clustered in the tail region. By 42 hpf, PLLP migration is achieved and 6 hours later all the neuromasts are fully differentiated (Gompel et al., 2001; Ledent, 2002) . Neuromasts are innervated by bipolar sensory neurons that also differentiate from the PLL placode. These neurons are clustered into two cranial ganglions and send out two axons each, one into the hindbrain and the second into the PLLP (Metcalfe et al., 1985) . Evidence suggests that their growth cones contact the cells of the PLLP before the beginning of migration and remain associated with these cells throughout their journey (Metcalfe, 1985) . Previous studies have identified the chemokine receptors CXCR4b and CXCR7 and their ligand SDF-1a as the components of a signalling pathway that plays a key role in PLLP migration (David et al., 2002; Li et al., 2004; Sapède et al., 2005; Haas et al., 2006; Dambly-Chaudière et al., 2007; Valentin et al., 2007) .
We demonstrated an essential requirement for anosmin-1a, but not for anosmin-1b, in PLLP migration. We found that while the differentiation of the PLLP was not impaired in kal1a morphant, its journey was severely compromised following morpholino-mediated kal1a inactivation. We also showed that kal1a transcription is independent of CXCR4b/SDF1a signalling. Last, we observed that moderate depletion of both anosmin-1a and SDF1a markedly affects PLLP migration, strongly suggesting that anosmin-1a is an essential co-factor in SDF1a-mediated signalling.
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Materials and methods
Zebrafish Strains
Zebrafish (Danio rerio) were maintained as described by Westerfield (1995) .
Embryos were produced in our facility using standard conditions. Wild-type embryos were from the AB strain. Transgenic animals from the H 2 A.F/Z::GFP and ClaudinB::GFP transgenic lines were kindly provided by J. Campos-Ortega (Pauls et al., 2001 ) and D. Gilmour (Haas et al., 2006) , respectively.
DASPEI labelling
Hair cells were labelled by incubating 5 dpf living embryos in DASPEI solution (100 µg/ml in fish water) for 10 min at room temperature. Embryos were quickly rinsed in fish water, oriented in methylcellulose (3% in fish water), imaged using a 5 X objective mounted on a Leica DMRBE microscope equipped with a Nikon digital Sight DS-U1 camera and the stained neuromasts were counted unilaterally.
Antibody production
Two rabbit polyclonal antibodies raised against zebrafish anosminU 1a (Genbank AF163310) have been generated: α anosmin1a-A and α anosmin1a-B, which are directed against peptides corresponding to N-terminal residues 151 to 197 and C-terminal residues 1051 to 1096, respectively. We have also generated two rabbit polyclonal antibodies directed against anosmin-1b (Genbank AF163311): α anosmin1b-A and α anosmin1b-B, which are directed against peptides including N-terminal residues 51 to 102 and C-terminal residues 851 to 899, respectively. All antibodies were affinity purified and their specificity was verified by Western blots. Substitution of the purified anti-anosmin-1a or anti-anosmin-1b antibodies by the pre-immune sera and pre-adsorption of the antibodies with the corresponding antigens were used as negative controls.
Western blotting
Zebrafish protein extracts were analyzed by immunoblotting as described by Gershoni and Palade (1983) . Anti-anosmin-1a-A and anosmin-1b-A were used at a 1:1,000 dilution. Horseradish peroxidase (HRP)-conjugated anti-rabbit antibody was inserm-00289099, version 1 -2 Jul 2008 used as secondary antibodies at a 1:6000 dilution, and chemiluminescence was detected using the ECL kit (Amersham).
Morpholino-mediated gene Inactivation
To inactivate the translation of kal1a RNAs, we designed a morpholinooligonucleotide, MO kal1a (5'-GGTGAGCCCGTCTCGCATCTTGAAG-3'), which is complementary to the sequence flanking on the both sides the translation initiating codon of the kal1a RNA (underlined). Similarly, we designed a morpholino aimed at inhibiting the translation of kal1b RNAs, MO kal1b
(5'-GCAGAGATTCCTCAAAAGCAGCATC-3'). As control, we first designed a morpholino oligonucleotide derived from MO kal1a but comprising five mismatching bases (lower case letters), mmMO kal1a,
(5'-GGTcAGgCCGTgTCGCATgTTcAAG-3'). We also used a non-specific morpholino oligonucleotide, MO control (5'-CCTCTTACCTCAGTTACAATTTATA-3').
To inactivate the translation of cxcr4b and sdf1a RNAs, C. Dambly-Chaudière and A.
Ghysen kindly provided us with MO cxcr4b (5'-ATGATGCTATCGTAAAATTCCATTT-3') and MO sdf1a (5'-ATCACTTTGAGATCCATGTTTGCA-3'). For morpholinomediated transcript inactivation experiments, solutions 0.1, 0.25 or 0.5 mM of the different morpholinos were injected using standard protocols. For double inactivation of kal1a and kal1b transcripts, a mix of MO kal1a and MO kal1b, 0.25 mM each, was injected. For double inactivation of kal1a and sdf1a RNAs, a mix of MO kal1a and MO sdf1a, 0.1 mM each, was injected.
Production of a kal1a morpholino-insensitive kal1a RNA
To synthesize MO kal1a-insensitive kal1a transcripts, the complete translated sequence of a kal1a cDNA was subcloned as XhoI-XbaI fragment in the pCS2+ plasmid. A mutated version of kal1a protein coding sequence was obtained by PCR using a forward oligonucleotide complementary to the kal1a DNA sequence flanking the ATG codon and including 7 mis-matches mutations (lower case letters): 5' cTCgAGATGCGcGAtGGaCTtACtGGTTTG 3' and containing a Xho I restriction site (5' to the ATG), and a reverse oligonucleotide that binds 3' to the termination codon and containing a Xba I restriction site (note that all mutations do not change the amino acid sequence of anosmin-1a). The PCR product was then cloned as Xho IXba I fragment in the pCS2+ plasmid to generate the pCS2+/kal1a construct. This plasmid was linearized by Not I digestion and then used as templates for in vitro inserm-00289099, version 1 -2 Jul 2008
transcription. MO kal1a-insensitive kal1a RNA was generated using the SP6 mMESSAGE mMACHINE kit (AMBION) following the protocol provided by the manufacturer.
Phenotypic rescue
For rescue experiments, a mix containing MO kal1a (0,5 mM) and MO kal1a-insensitive kal1a mRNA (1 µM), was injected into embryos at the one-to two-cell stage according to standard protocols and the phenotypes were analysed at the indicated stages.
Whole-mount in situ hybridization
In situ hybridization was performed as described in R&D Systems kit (R&D Systems Europe, Lille, France). The following cDNA were used as templates to 
Immunofluorescence on whole mount embryos
Embryos were fixed in 4% formaldehyde in PBS for 1h at room temperature, washed three times in PBS (10 mn each) and incubated overnight at 4°C with the anti-anosmin-1a or anti-anosmin-1b antibodies diluted 1:1000 or anti-acetylated β-tubulin antibodies diluted 1:200 in PBS containing 1% bovine serum albumin.
Following incubation with primary antibodies, embryos were incubated with Alexa 488-conjugated goat anti-rabbit Fab'2 antibodies diluted 1:500 in PBS supplemented with 1% BSA for 1h at room temperature, washed as previously described and oriented in methylcellulose (3% in fish water).
PLL nerve labelling and time-lapse microscopy
In vivo imaging of posterior lateral line primordium (PLLP) migration was performed in H 2 A.F/Z::GFP transgenic (WT) (Pauls et al., 2001) 
Statistics
Statistical analysis was performed using one-way ANOVA.
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RESULTS
Kal1a and kal1b are transcribed in the migrating cells of the PLLP
The PLLP forms just caudal to the otic vesicle at 18 hpf and at 20 hpf starts migrating toward the caudal region to reach the tip of the tail by 40 hpf (for reviews, 
Distribution of anosmin-1a and anosmin-1b during PLL differentiation
We then studied the distribution of anosmin-1a and anosmin-1b throughout PLLP migration using specific antibodies (see Materials and methods). The distribution of the two proteins does not precisely fit that of the corresponding RNAs.
At 20 hpf, in close agreement with in situ hybridization data, both proteins were present in the newly differentiated PLLP (data not shown). From 26 hpf onward, anosmin-1a and anosmin-1b accumulated in the centre of the trailing region of the PLLP and, in close agreement with our previous data (Ernest et al., 2007) , from 32 hpf onward, both proteins were detected in differentiated neuromasts ( Fig. 1L -O).
Anosmin-1a and anosmin-1b were also distributed along the myoseptum as a discontinuous thin strip extending along the trailing path of the migrating primordium ( Fig. 1L and O). In the head region, anosmin-1a was found in the anterior lateral line primordium (ALLP) and head neuromast hair cells (supplementary Fig. 2A -B'').
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Kal1a inactivation impairs neuromast deposition
We used morpholino-mediated gene knock-down to study the consequences of . These data thus demonstrate the efficiency of the morpholinos used in this study.
First, we analysed the differentiation of the PLL in kal1a and kal1b morphants by counting the number of neuromasts deposited along the flanks and tail of embryos at 3 dpf using the fluorescent vital dye DASPEI (Whitfield et al., 1996) ( Fig. 2A-F ).
Non-injected embryos (WT) and embryos injected with mmMO kal1a (0.5 mM) displayed 7.37 ± 0.26 (n = 150) and 6.17 ± 0.42 (n = 120) neuromasts per side, respectively ( Fig number of neuromasts observed in kal1a morphants was not due to a non-specific effect of the morpholino used in this study, we tested whether co-injection of a kal1a MO-insensitive kal1a RNA was able to rescue the neuromast deposition defect observed in kal1a morphants. The results show that in embryos co-injected with MO kal1a (0.5 mM) and kal1a MO-insensitive kal1a RNA (1 µM), the number of deposited neuromasts, 6.15 ± 0.45 (n = 96) (Fig. 2F) , was not significantly different from that observed in wild-type embryos (p<0,05) or mmMO kal1a morphants (p<0,01). In addition, at 4, 5, and 8 dpf, while the number of deposited neuromasts inserm-00289099, version 1 -2 Jul 2008
was on average similar in wild-type and kal1b morphants, their numbers were reduced by 93 to 100% and 92 to 100% in kal1a morphants, compared with wild-type or MO kal1b-injected embryos, respectively (p<0.01; Fig. 2G ). These results demonstrate that the absence of neuromasts in kal1a morphants was not the consequence of a delayed differentiation of proneuromasts into neuromasts.
Moreover, comparative analysis of the pigmentation pattern together with eye and mouth differentiation in MO kal1a (0.5 mM) morphants aged between 3 and 5 dpf
show that embryonic development, and consequently LL differentiation, were not significantly delayed in anosmin-1a-depleted embryos compared with wild-type embryos (supplementary Fig. 3A-D' ). To ascertain that the reduced number of neuromasts observed in kal1a morphants was not the mere consequence of the absence of hair cells, we combined DASPEI staining with transgenic ClaudinB:GFP embryos as recipients for morpholino injection. Results show that in MO kal1a (0.25 mM) morphants, almost all deposited neuromasts display hair cells ( and Fig. 2J -K''), these data suggest that anosmin-1a also plays a role in terminal differentiation of these cells. The lack of neuromasts in strong MO kal1a (0.5 mM) morphants was confirmed independently using scanning electron microscopy (data not shown). By contrast, both morpholino-mediated loss-of-function and RNA injection-mediated over-expression experiments show that kal1b does not play an essential role in PLL differentiation. Therefore, we did not investigate the function of this gene any further here.
We also observed that the formation of the anterior LL was affected, though at milder levels, following kal1a inactivation. In embryos injected with MO kal1a (0.25 mM) or (0.5 mM) a reduction of approximately 50 and 80%, respectively, of the number of cephalic neuromasts was observed compared with wild-type embryos ( Fig. 2A-C) .
Essential requirement for anosmin-1a in PLLP migration
The lack of PLL neuromasts in kal1a morphants may be the consequence of the failure of several developmental processes: (i) PLLP differentiation, (ii) correct inserm-00289099, version 1 -2 Jul 2008 migration of the PLLP along the body axis, and/or (iii) the deposition of proneuromasts from the migrating primordium. To address these issues and determine whether the PLLP properly differentiate and (or) migrate in kal1a morphants, these embryos were analysed first at 28 hpf by in situ hybridization using a cxcr4b probe, which strongly labels the PLLP throughout its migration (David et al., 2002) . In wild-type (Fig. 3A) and mmMO kal1a (0.5 mM) embryos (Fig. 3C ), a strong labelling of the PLLP was observed throughout its journey toward the tip of the tail.
High levels of cxcr4b transcripts were also detected in the PLLP of kal1a morphants.
However, in these embryos, cxcr4b staining revealed that PLLP migration was severely abrogated (Fig. 3B) . These findings strongly suggest that kal1a inactivation does not inhibit PLLP differentiation, but markedly compromises its migration.
To further assess the specificity of MO kal1a-mediated gene inactivation, embryos were injected with kal1a MO-insensitive kal1a RNA (1µM) alone or coinjected with MO kal1a (0.5 mM) and kal1a MO-insensitive kal1a RNA (1µM), and then hybridized with a cxcr4b probe. Cxcr4b staining revealed that the PLLP was located at a similar position along the body axis in wild-type embryos compared with those injected with kal1a MO-insensitive kal1a RNA (compare Fig. 3A with D) ,
showing that injection of the modified in vitro transcribed kal1a RNA did not affect PLLP migration. Similarly, results showed that PLLP migration was not impaired in embryos co-injected with MO kal1a and kal1a MO-insensitive kal1a RNA when compared with wild-type embryos or those injected with the kal1a MO-insensitive kal1a RNA alone (compare Fig. 3E with 3A and D ). These data demonstrate that exogenously supplied anosmin-1a is able to fully overcome the lack of the endogenous protein and thus the specificity of the effect of MO kal1a-mediated gene inactivation on PLLP migration.
To investigate the consequences of kal1a inactivation on the morphology of the PLLP, we used ClaudinB::GFP embryos as recipients for MO kal1a injection. These embryos display an intense fluorescent labelling of all derivatives of sensory placodes, including the PLLP (Haas et al., 2006) (Fig. 4A and A' ). In close agreement with cxcr4b staining, results confirm that PLLP migration was severely impaired in ClaudinB::GFP MO kal1a morphants (0.5 mM) (n=51) (Fig. 4B-C' ). In addition, while the PLLP displayed a stretched morphology in non-injected embryos (Fig. 4A') , the PLLP of ClaudinB::GFP kal1a morphants showed abnormal morphologies, being either rounded (n=48) (Fig. 4B') or C-shaped (n=3) (Fig. 4C') .
Kal1a inactivation induces a severe freeze of PLLP migration
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While our data show that migration of the PLLP is severely impaired in kal1a morphants, we cannot rule out the possibility that the journey of the PLLP is not frozen but only severely slowed. To establish whether kal1a inactivation impairs PLLP migration or only severely reduces its speed, we followed primordium migration in vivo by time-lapse analysis using H 2 A.F/Z::GFP (Pauls et al., 2001) and ClaudinB::GFP transgenic embryos (Haas et al., 2006) as recipients for MO kal1a (0.5 mM) injection. In addition, we injected the fluorescent vital dye DiI in the PLLP ganglion at 22 hpf to visualize PLLP sensory neurons and their axons, and thus follow the location of the PLLP nerve respectively to the migrating primordium. In close agreement with earlier observations (Metcalfe, 1985; Gompel et al., 2001) , in vivo imaging revealed that in wild-type embryos, the PLLP migrated at a speed of approximately 1.5 somites per hour (Fig. 5A , C, C' and C'' and supplementary Movies 1 and 3). In contrast, the PLLP and its associated nerve were immobilized in MO kal1a (0.5 mM) morphants, thus confirming that kal1a inactivation severely impairs PLLP migration (Fig. 5B, D 
, D' and D'' and supplementary Movies 2 and 4).
However, In MO kal1a (0.25 mM) morphants, while the PLLP nerve migrated up to the trailing region of the PLLP, its nerve fibres did not extend within the primordium (supplementary Fig. 4 ). These data demonstrate that while kal1a inactivation does not block the elongation of the PLLP nerve, it impairs the full extension of sensory neuron axons within the migrating PLLP.
Transcription of kal1a in the migrating PLLP is independent of CXCR4b/SDF-1 signalling
It has been shown that cxcr4b, which encodes a chemokine receptor, and one of its ligands, SDF1a, play key roles during PLLP migration in zebrafish embryos (David et al., 2002; Li et al., 2004; Sapède et al., 2005; Haas et al., 2006) . In the migrating PLLP, cxcr4b transcription is detected in the posterior half of the primordium that contains migrating cells, and is down-regulated in the cells of the trailing region (Gompel et al., 2001) , as is also the case for the kal1a gene. The coexpression of the two genes in the migrating cells of the PLLP suggests that the CXCR4b receptor may positively regulate kal1a transcription.
To test this hypothesis, we investigated by in situ hybridization whether kal1a transcription was down-regulated following morpholino-mediated inactivation of the cxcr4b or sdf1a genes. As previously described, in the absence of SDF1a or CXCR4b, the migration of the PLLP is blocked (David et al., 2002; Li et al., 2004;  inserm-00289099, version 1 -2 Jul 2008 Sapède et al., 2005; Haas et al., 2006; Dambly-Chaudière et al., 2007; Valentin et al., 2007) . However, the expression of the kal1a gene in the PLLP, notwithstanding its location along the body axis, was not significantly altered in cxcr4b (Fig. 6B) or sdf1a ( Fig. 6C ) morphants compared with wild-type embryos (Fig. 6A ). Thus transcription of the kal1a gene in the migrating PLLP is independent of the CXCR4b/SDF1a signalling pathway.
Moderate depletion of both anosmin-1a and SDF1a markedly affects PLLP migration
While kal1a transcription in PLLP cells is independent of CXCR4b/SDF1a signalling, co-expression of the kal1a and cxcR4b or cxcR7 genes in PLLP cells, also suggests that the cell matrix protein anosmin-1a may be a cofactor of CXCR4b or CXCR7 in SDF1a-mediated signalling.
To test this hypothesis, we investigated by morpholino injections whether moderate depletion of both anosmin-1a and SDF1a compromises PLLP migration.
Interestingly, results show that while the journey of the PLLP was not significantly impaired in MO sdf1a (0.1 mM) (n=32) (Fig. 7B ) and MO kal1a (0.1 mM) (n=73) (Fig.   7C ) morphants, embryos co-injected with MO kal1a and MO sdf1a (0.1 mM each) (n=41) display severe PLLP migration defects ( Fig. 7D-D'' ), reminiscent to those observed in strong MO kal1a (0.5 mM) morphants (compare Fig. 7D '' with Fig. 4B') , thus strengthening the hypothesis that anosmin-1a is an essential co-factor in SDF1a-mediated signalling.
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DISCUSSION
We demonstrate here an essential requirement for the zebrafish kal1a gene in PLLP migration. We had previously shown that in the inner ear and in differentiated neuromasts, anosmin-1a is accumulated at the surface of hair cells, suggesting a hitherto unknown function for this protein in mechanosensory cells (Ernest et al., 2007) . Thus our findings provide strong evidence that anosmin-1a plays different roles during the differentiation of the PLL. In particular, our results suggest that anosmin-1a is an essential co-factor in SDF1a/CXCR4b and/or SDF1a/CXCR7 signalling pathways.
Anosmin-1a plays an essential role during PLLP migration
The severe PLLP migration defect observed in kal1a morphants, which can be rescued by co-injecting a morpholino-insensitive kal1a RNA, provides strong evidence that anosmin-1a plays an essential role during the journey of the PLLP. In addition, both the specific transcription of kal1a and the accumulation of anosmin-1a in the migrating PLLP suggest a direct requirement for this protein in the migratory properties of PLLP cells.
Anosmin-1 is an ECM protein also required for the migration of another cell population, the GnRH synthesizing neurons. In close agreement with the migration defect of GnRH cells observed in Kallmann's patients (Schwandzel-Fukuda et al., 1989) , previous works have established that anosmin-1a plays an essential and evolutionarily conserved role during the migration of GnRH neurons from the olfactory placode to the brain in both zebrafish (Whitlock et al., 2005) and medaka (Okubo et al., 2006) . In these cases, while the kal1a gene is not expressed in the migrating GnRH neurons (Okubo et al., 2005) , it is transcribed in the olfactory bulbs, which are a step point along the migration path of these neurons during their journey to the hypothalamus. In addition, in vitro experiments in mammals have shown that exogenously supplied anosmin-1 displays a specific chemotactic activity on immortalized mouse GnRH neurons (GN11) (Cariboni et al., 2004) .
We have also demonstrated that zebrafish anosmin-1a, like human anosmin-1 (Soussi-Yanicostas et al., 1996; 1998; Robertson et al., 2001) , is a secreted protein and an ECM component that displays several activities in vitro, including axon growth and guidance and, of particular interest here, cell adhesion (Soussi-Yanicostas, unpublished data). In addition, two mutations that abolish the chemotactic activity of anosmin-1 on GnRH (GN11) neurons (Cariboni et al., 2004 ) also affect the cell inserm-00289099, version 1 -2 Jul 2008 adhesion properties of the protein (Robertson et al., 2001) , suggesting a possible direct link between these two activities. Overall, these data suggest that during GnRH neuron migration, anosmin-1/anosmin-1a acts non-autonomously and plays a role as a guidance cue and (or) migration substrate.
By contrast, during the journey of the PLLP, both the accumulation of anosmin1a in the PLLP from approximately 20 hpf onward, just before the onset of migration, and the phenotypes of the PLLP of kal1a morphants, suggest that the PLLP migration defect is the result of a cell autonomous defect affecting PLLP cells, which inhibits their ability to move. In particular, the severe migration defect observed following partial depletion of both anosmin-1a and SDF1a, provides strong evidence that anosmin-1a plays an essential role for proper activation of SDF1a-mediated signalling in PLLP cells expressing CXCR4b and/or CXCR7. This hypothesis is also reinforced by the rounded phenotype of the PLLP observed in approximately 94% of kal1a morphants (48/51), which is reminiscent of that observed in cxcr4b mutants (Hass et al., 2006) . Also, the C-shaped phenotype of the PLLP observed in approximately 5% of kal1a morphants, suggests that following kal1a inactivation, part of the PLLP cells may be attracted by the ventral expression domain of SDF1a located at the level of the pronephros (David et al., 2002) . Altogether, these data strongly suggest an essential requirement for anosmin-1a in SDF1a/CXCR4b and/or SDF1a/CXCR7 signalling.
Given the results of in vitro studies, which have demonstrated that anosmin-1 binds directly to urokinase-type plasminogen activator and activates its amidolytic activity (Hu et al., 2004) , an attractive hypothesis would be that anosmin-1/anosmin1a acts as a scaffold protein that recruits proteases and locally increases the proteolytic degradation of extracellular matrix components, and thus the release or activation of growth factors or receptor ligands, including SDF1a.
Multiple requirements for anosmin-1a in lateral line differentiation
Transcription of the kal1a gene is detected first in the newly differentiated PLLP at approximately 20 hpf and throughout its migration, kal1a RNAs are specifically expressed in the posterior region of the primordium that contains the migrating PLLP cells. In addition, from 36 hpf onward, kal1a transcript accumulation is also observed in the newly deposited neuromasts. In contrast, throughout the journey of the PLLP,
anosmin-1a accumulation is detected in the centre of the anterior region, along the trailing path of the primordium and, in close agreement with our previous results (Ernest et al., 2007) In addition, the accumulation of anosmin-1a along a thin discontinuous strip extending along the trailing path of the migrating primordium also suggests that a secreted form of anosmin-1a is deposited by the cells of the migrating primordium at the surface of underlying mesodermal cells. This hypothesis is supported by previous data showing that human anosmin-1 is a secreted protein (Soussi-Yanicostas et al., 1996; Rugarli et al., 1996) . An interesting possibility is that this deposited form of anosmin-1a might play a role in the full maturation of the adjacent PLL nerve, such as the guidance of glial cells along sensory neuron axons or proper myelinisation of the nerve fibres. In this context, it is interesting to note that while the LL nerve elongates up to the trailing edge of the PLLP whatever its position along the A-P axis in intermediate MO kal1a (0.25 mM) morphants, its axons do not properly defasciculate nor enter the primordium, suggesting a possible role for anosmin-1a in terminal elongation of the LL nerve or proper innervation of the PLLP.
Anosmin-1b is dispensable for PLLP migration and neuromasts deposition
Intriguingly, while both kal1a and kal1b RNAs are transcribed in the PLLP throughout its journey, the analysis of kal1b morphants and kal1a-kal1b doublemorphants strongly suggests that anosmin-1b is fully dispensable for PLLP migration. As mentioned above, Whitlock et al. (2005) and Okubo et al. (2006) However, none of these defects are observed following MO kal1b-mediated gene inactivation (Whitlock et al., 2005 and our results), the efficiency of which was confirmed by Western blot, and no abnormalities were detected following inactivation of the kal1.2 RNAs (Okubo et al. 2006) . Given the levels of sequence similarities between the zebrafish kal1a and kal1b and the medaka kal1.1 and kal1.2 genes, Okubo et al. (2006) have proposed that kal1.1 and kal1.2 are the orthologues of kal1a and kal1b, respectively. In this context, it is interesting to note that: (i) inserm-00289099, version 1 -2 Jul 2008
anosmin-1b lacks the basic C-terminal domain found in all vertebrate anosmin-1 so far characterized, (ii) its N-terminal cysteine-rich region contains amino acid substitutions that affect two cysteine residues, which are conserved in all other vertebrate anosmin-1 and (iii) its WAP motif also displays three amino acid substitutions that affect residues that are conserved in all vertebrate anosmin-1 (supplementary Fig. 6 ). The lack of detectable phenotypes in embryos following kal1b/kal1.2 inactivation combined with the absence of the basic C-terminal domain in this protein and the amino acid substitutions described above, raise questions about the function of the kal1b/kal1.2 genes. However, given its structure and sequence, it is very unlikely that kal1b is a pseudogene. Also, this gene, which arose from a gene duplication predating the divergence of teleosts and tetrapods (Okubo et al., 2006) , is conserved in both the medaka and zebrafish. Taken together, these data suggest that anosmin-1b plays a role in processes that remain to be discovered.
Our data identify the ECM protein anosmin-1a as an essential factor for PLLP 
